The role of matrix metalloproteinase-9 in dementia
- 22 August 2003
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 350 (3) , 181-183
- https://doi.org/10.1016/s0304-3940(03)00905-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's diseaseNeurochemistry International, 2003
- β-Amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytesBrain Research, 2003
- Poststroke DementiaArchives of Neurology, 2003
- Incidence of Dementia After Ischemic StrokeStroke, 2002
- Amyloid-β oligomers: their production, toxicity and therapeutic inhibitionBiochemical Society Transactions, 2002
- β‐Amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?Journal of Neurochemistry, 2002
- Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 GeneArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Cardiovascular factors in Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1998
- The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairmentNeuroscience Letters, 1996
- Characterization of Neutral Proteinases from Alzheimer‐Affected and Control Brain Specimens: Identification of Calcium‐Dependent Metalloproteinases from the HippocampusJournal of Neurochemistry, 1992